Flex to Participate in Upcoming Investor Conference
Flex to Participate in Upcoming Investor Conference
PR Newswire
AUSTIN, Texas, Feb. 26, 2024
AUSTIN, Texas, Feb. 26, 2024 /PRNewswire/ -- Flex (NASDAQ: FLEX) has announced members of its leadership team will participate in the upcoming investor conference:
Raymond James 2024 Institutional Investors Conference
Date: Monday, March 4, 2024
Presentation time: 5:05am PT / 8:05am ET
The presentation will be available as a live webcast accessible through the Flex Investor Relations website at https://investors.flex.com. An archived replay will be available on the website shortly after the conclusion of the presentation.
About Flex
Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets.
Contacts
Investors & Analysts
David A. Rubin
Vice President, Investor Relations
(408) 577-4632
David.Rubin@flex.com
Media & Press
Yvette Lorenz
Director, Corporate PR and Executive Communications
(415) 225-7315
Yvette.Lorenz@flex.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/flex-to-participate-in-upcoming-investor-conference-302071527.html
SOURCE Flex
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand